LENSAR Inc Ordinary Shares LNSR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $6.00
- Day Range
- $5.89–6.20
- 52-Week Range
- $5.06–13.43
- Bid/Ask
- $5.93 / $6.32
- Shares Outstanding
- 12.28M
- Market Cap
- $72.83M
- Volume/Avg
- 25,991 / 82,357
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.37
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 150
- Website
- https://www.lensar.com
Valuation
|
Metric
|
LNSR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.87 |
Price/Sales | 1.37 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LNSR
|
|---|---|
Quick Ratio | 1.05 |
Current Ratio | 2.38 |
Interest Coverage | — |
Quick Ratio
LNSR
Profitability
|
Metric
|
LNSR
|
|---|---|
Return on Assets (Normalized) | −5.55% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
LNSR
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|tXkq<CZ | LOCK|G!!< | $164B | |||
| Stryker Corp
SYK
| LOCK|qv@Dx!Vn | LOCK|B% | $125B | |||
| Medtronic PLC
MDT
| LOCK|j>s!LNc | LOCK|!SX! | $105B | |||
| Boston Scientific Corp
BSX
| LOCK|Lx%>^j# | LOCK|nfd% | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|?nB!nS#n | LOCK|BV#^ | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|>pM^rMq | LOCK|kh | $29B | |||
| DexCom Inc
DXCM
| LOCK|n#>%g!>$ | LOCK|#Z>$r | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|hPJ | LOCK|ryw | $27B | |||
| Steris PLC
STE
| LOCK|j!tTmS | LOCK|XGh&? | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|FFM^ny& | LOCK|b^ | $17B |
United States